Published in Cytotechnology on June 01, 2005
"Humanized" stem cell culture techniques: the animal serum controversy. Stem Cells Int (2011) 1.18
Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction. J Neural Transm (Vienna) (2014) 0.75
PDGF signaling in cells and mice. Cytokine Growth Factor Rev (2004) 2.57
Transforming growth factor-beta. Multiple actions and potential clinical applications. JAMA (1989) 1.40
The use of fetal bovine serum: ethical or scientific problem? Altern Lab Anim (2002) 1.35
Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. Mol Cancer Res (2003) 1.28
Platelet-derived growth factor and its role in health and disease. Philos Trans R Soc Lond B Biol Sci (1990) 1.27
The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro (2004) 1.25
Immortalization of primary human smooth muscle cells. Proc Natl Acad Sci U S A (1992) 1.21
Spatial organization of extracellular matrix and fibroblast activity: effects of serum, transforming growth factor beta, and fibronectin. Exp Cell Res (1990) 1.17
Sending the signal: molecular mechanisms regulating glucose uptake. Med Sci Sports Exerc (2004) 1.15
Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX (2003) 1.13
Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci (2003) 1.11
Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists. Am J Physiol Endocrinol Metab (2005) 1.07
Muscle-derived stem cells for musculoskeletal tissue regeneration and repair. Transpl Immunol (2004) 1.04
Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnology (2003) 0.94
Serum-free culture of hematopoietic stem cells: a review. Stem Cells (1995) 0.93
Human skeletal muscle cell differentiation is associated with changes in myogenic markers and enhanced insulin-mediated MAPK and PKB phosphorylation. Acta Physiol Scand (2004) 0.93
Culture media for propagation of mammalian cells, viruses, and other biologicals. Adv Biotechnol Processes (1985) 0.91
The effects of platelet-derived growth factor-BB on periodontal cells in an in vitro wound model. J Periodontol (2001) 0.90
Down-regulation of platelet-derived growth factor receptor signaling during myogenesis. Cell Mol Life Sci (2003) 0.80
Use of plant-derived protein hydrolysates for enhancing growth of Bombyx mori (silkworm) insect cells in suspension culture. Biotechnol Appl Biochem (2005) 0.79
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med (2011) 3.31
TXNIP regulates peripheral glucose metabolism in humans. PLoS Med (2007) 3.27
Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab (2009) 2.76
Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab (2012) 2.46
Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes (2005) 2.35
Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle. Diabetes (2008) 2.03
Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell (2008) 1.97
Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes (2005) 1.89
siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab (2006) 1.48
Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology (2009) 1.47
Strenuous physical exercise adversely affects monocyte chemotaxis. Thromb Haemost (2010) 1.45
Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol (2006) 1.43
Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes (2004) 1.43
Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem (2007) 1.40
Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes (2007) 1.37
Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle. Am J Physiol Endocrinol Metab (2003) 1.32
Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep (2013) 1.31
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab Res Rev (2011) 1.30
Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. Diabetes (2005) 1.28
Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol Rev (2009) 1.27
MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am J Physiol Cell Physiol (2004) 1.16
Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003) 1.13
Low-intensity exercise increases skeletal muscle protein expression of PPARdelta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev (2006) 1.11
Pax6 controls the expression of critical genes involved in pancreatic {alpha} cell differentiation and function. J Biol Chem (2010) 1.07
IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis. J Immunol (2004) 1.04
Epigenetic flexibility in metabolic regulation: disease cause and prevention? Trends Cell Biol (2012) 1.04
siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle. Diabetes (2008) 1.02
ERK1/2 mediates insulin stimulation of Na(+),K(+)-ATPase by phosphorylation of the alpha-subunit in human skeletal muscle cells. J Biol Chem (2004) 1.00
In vitro proliferation of adult human beta-cells. PLoS One (2012) 0.99
Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Diabetes (2012) 0.98
Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus. Metabolism (2011) 0.97
Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Am J Physiol Endocrinol Metab (2013) 0.97
Exercise and the treatment of diabetes and obesity. Med Clin North Am (2011) 0.96
Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One (2013) 0.96
Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism. J Biol Chem (2006) 0.95
Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes. Diabetes (2011) 0.94
Suppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle. J Biol Chem (2011) 0.91
Altered response of skeletal muscle to IL-6 in type 2 diabetic patients. Diabetes (2012) 0.89
Arginase inhibition reduces infarct size via nitric oxide, protein kinase C epsilon and mitochondrial ATP-dependent K+ channels. Eur J Pharmacol (2013) 0.88
Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects. Diabetes (2004) 0.87
Exercise and the treatment of diabetes and obesity. Endocrinol Metab Clin North Am (2008) 0.86
Differential expression of metabolic genes essential for glucose and lipid metabolism in skeletal muscle from spinal cord injured subjects. J Appl Physiol (1985) (2011) 0.86
Endothelin-1 reduces glucose uptake in human skeletal muscle in vivo and in vitro. Diabetes (2011) 0.85
Testosterone or 17{beta}-estradiol exposure reveals sex-specific effects on glucose and lipid metabolism in human myotubes. J Endocrinol (2011) 0.85
RNA interference-mediated reduction in GLUT1 inhibits serum-induced glucose transport in primary human skeletal muscle cells. Biochem Biophys Res Commun (2003) 0.84
Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake. Am J Physiol Endocrinol Metab (2004) 0.84
Regulation of glucose uptake by endothelin-1 in human skeletal muscle in vivo and in vitro. J Clin Endocrinol Metab (2010) 0.83
Insulin signalling and resistance in patients with chronic heart failure. J Physiol (2003) 0.82
Altered content of AMP-activated protein kinase isoforms in skeletal muscle from spinal cord injured subjects. Am J Physiol Endocrinol Metab (2013) 0.81
Glucocorticoid-mediated effects on metabolism are reversed by targeting 11 beta hydroxysteroid dehydrogenase type 1 in human skeletal muscle. Diabetes Metab Res Rev (2009) 0.80
Gene expression of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in skeletal muscle from type 2 diabetic subjects. Pflugers Arch (2002) 0.78
Phosphorylation of the Na+,K+-ATPase in skeletal muscle: potential mechanism for changes in pump cell-surface abundance and activity. Ann N Y Acad Sci (2003) 0.76
ContRac1ion-mediated glucose uptake: a central role for Rac1. Diabetes (2013) 0.75
Maternal obesity legacy: exercise it away! Diabetologia (2016) 0.75
Time to look back and to look forward. Diabetes (2014) 0.75
[Molecular mechanisms underlying insulin resistance in skeletal muscle]. Lakartidningen (2010) 0.75